Safety and Feasibility of Umbilical Cord Wharton's Jelly Allograft Injections for Knee Osteoarthritis
NCT06608134
This study is recruiting at 5 US sites in 4 states, according to its ClinicalTrials.gov record last updated .
Summary
This is a Pilot Study which is randomized, prospective, open label, dose escalation, non-controlled evaluating safety and feasibility of intra-articular Wharton's Jelly (WJ) allograft will be evaluated in patients suffering with knee osteoarthritis. The participants will be randomized to one of three dosing treatment arms that will consist of one intra-articular knee injection containing either low dose, medium dose or high dose WJ allograft tissue.
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- Osteoarthritis, Knee
Eligibility basics and study details
- Study type
- Interventional
- Phase
- Early Phase 1
- Ages
- 30 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Sponsor
- R3 Medical Research
- Last updated on ClinicalTrials.gov
- September 23, 2024
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
Arizona · 1
- R3 Anti Aging Scottsdale · Scottsdale, AZ
California · 2
- R3 Anti Aging Beverly Hills · Beverly Hills, CA
- Optimal Medical Group · Fresno, CA
New York · 1
- Scheer Medical Wellness · New York, NY
Texas · 1
- Dr. Duc (Steve) Le, MD · Cleveland, TX
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.